Pharmacokinetic and metabolomic analyses of Mangiferin calcium salt in rat models of type 2 diabetes and non-alcoholic fatty liver disease

Abstract

Background: Non-alcoholic fatty liver is one of the most common comorbidities of diabetes. It can cause disturbance of glucose and lipid metabolism in the body, gradually develop into liver fibrosis, and even cause liver cirrhosis. Mangiferin has a variety of pharmacological activities, especially for the improvement of glycolipid metabolism and liver injury. However, its poor oral absorption and low bioavailability limit its further clinical development and application. The modification of mangiferin derivatives is the current research hotspot to solve this problem. Methods: The plasma pharmacokinetic of mangiferin calcium salt (MCS) and mangiferin were monitored by HPLC. The urine metabolomics of MCS were conducted by UPLC-Q-TOF-MS. Results: The pharmacokinetic parameters of MCS have been varied, and the oral absorption effect of MCS was better than mangiferin. Also MCS had a good therapeutic effect on type 2 diabetes and NAFLD rats by regulating glucose and lipid metabolism. Sixteen potential biomarkers had been identified based on metabolomics which were related to the corresponding pathways including Pantothenate and CoA biosynthesis, fatty acid biosynthesis, citric acid cycle, arginine biosynthesis, tryptophan metabolism, etc. Conclusions: The present study validated the favorable pharmacokinetic profiles of MCS and the biochemical mechanisms of MCS in treating type 2 diabetes and NAFLD.

Emerging Roles on Immunological Effect of Indoleamine 2,3-Dioxygenase in Liver Injuries

“…By using wide-targeted metabolomics liquid chromatography-quadrupole time of flight mass spectrometry (LC-QTOF-MS) analysis, from the CCl 4 -induced liver fibrosis rat model group, urinary and serum metabolomics L-Trp increased significantly from 2 to week 8, which can be regarded as effective biomarkers for the diagnosis of hepatic fibrosis and therapeutic targets ( 74 ). These results agreed with other liver injury models showing similar findings such as α-naphthyl isothiocyanate (ANIT) induced liver injury models or non-alcoholic fatty liver disease models, L-Trp was screened for potential biomarkers of the early detection of liver fibrosis ( 73 , 75 , 76 ). In patients, Clària et al reported that KP activity showed a positive correlation with overall severity of cirrhosis.…”

Serum Metabolomic Analysis of Chronic Drug-Induced Liver Injury With or Without Cirrhosis

“…Indolepyruvate, indole-acetaldehyde, 3-hydroxy-anthranilate, 3-methoxy-anthranilate, and quinolinic acid are metabolites of tryptophan metabolism. Tryptophan and its metabolites affect the immune and nervous system functions of patients ( 24 ). Additionally, 3-hydroxy-anthranilate has been reported to significantly provoke impairment of energy metabolism by inhibiting the activities of complexes I and II of the respiratory chain ( 25 ).…”

Canagliflozin Improves Liver Function in Rats by Upregulating Asparagine Synthetase

“…Patients with diabetes are prescribed the long-term use of hypoglycemic drugs, most of which are metabolized by the liver and can cause severe liver damage [30]. In turn, abnormal liver function strongly influences drug metabolism and detoxification, leading to toxic side effects via drug-drug interactions [25, 31]. Therefore, drugs that can lower blood glucose levels while protecting the liver are urgently needed to improve patient care.…”